Procter & Gamble reported weak fiscal year 2026 results with only 1% organic sales and core earnings per share growth. The company forecasts modest 1–3% organic sales growth for fiscal year 2027 amid challenges from rising private label competition, cost pressures, and a significant $1 billion after-tax headwind. Despite these issues, P&G maintains strong free cash flow and a roughly 3% dividend yield. The recent $3.8 billion acquisition of Thorne aims to diversify growth but carries risks due to the premium paid. Overall, the current share price reflects fair value amid growing macroeconomic uncertainty, leading analysts to maintain a Hold rating.
As Treasury yields near a one-year high, most dividend stocks face pressure, but three Dividend Kings—Coca-Cola, Procter & Gamble, and Johnson & Johnson—have consistently increased their dividends every quarter since 2022. These companies maintain st...
The article compares two popular U.S. retirement income ETFs: Schwab U.S. Dividend Equity ETF (SCHD) and JPMorgan Equity Premium Income ETF (JEPI). SCHD focuses on growing qualified dividends from strong American companies, offering a lower yield (~3...
Procter & Gamble, Coca-Cola, and Colgate-Palmolive are highlighted for their decades-long track records of raising dividends even through recessions. These consumer staples companies generate strong free cash flow and show pricing power that supports...
Procter & Gamble remains a well-managed company but its stock is currently overvalued at 21.15 times its fiscal year 2027 earnings per share, with expected growth of only 1.3%. The company's dividend yield of 2.95% is less attractive compared to risk...
Procter & Gamble (P&G) and Colgate-Palmolive, both Dividend Kings, recently paid dividends with P&G offering a higher yield of 2.93% versus Colgate's 2.33%. P&G's dividend is better covered by earnings and free cash flow, providing a safer and more s...
